The consortium of the new project: TRANSCAN-3 Sustained collaboration of national and regional programmes in cancer research, funded by the European Commission under Horizon 2020 from 2021 to 2026 (Grant Agreement no. 964264),
has launched its first Joint Transnational Call co-funded by the European Commission (JTC 2021)
on the topic:
"Next generation cancer immunotherapy: targeting the tumour microenvironment"
28 funding organizations from 19 countries are participating.
The submission deadline for pre-proposals is on 29thof June 2021.
It is expected that consortia invited for the full-proposal stage will be asked to submit their proposal on November 2021.
The ERA-NET: Aligning national/regional translational cancer research programmes and activities - TRANSCAN-2 is a project funded by the European Commission under the EU framework programme Horizon2020 (Grant Agreement no. 643638) from 2015 to 2021.
It is the continuation of the previous ERA-NET on translational cancer research TRANSCAN, funded under the FP7 from 2011 to 2014.
TRANSCAN-2 is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 31 partners from 19 Countries.
The project is coordinated by the Ministry of Health, Italy
Coordinator: Dr. Giovanni Leonardi. Deputy coordinator: Dr. Gaetano Guglielmi
Dr. Silvia Paradisi
Italian National Institute of Health
Viale Regina Elena, 299
00161 Rome, Italy